Latest Administration News

360 Capital Mortgage REIT is appointing receivers across its Bathla-related loans and preparing to sell 162 homes, apartments, townhouses and land lots. The Trust retains $6.3 million in cash and expects monthly distributions to continue, but their level may fluctuate as recoveries progress.

Bubs Australia has secured permanent US FDA authorisation for three infant formula products, removing a regulatory barrier in the company’s largest market. The approval supports possible portfolio expansion and contract manufacturing, but the presentation contains no new earnings guidance or quantified financial benefit.

Emyria has secured a limited in-person speaking position at a US FDA hearing examining how psychedelic medicines could be delivered safely and at scale. The appearance gives the ASX-listed company a regulatory platform, but does not represent FDA approval, funding or a commercial agreement.

Golden Dragon Mining has extended the Cue Gold Project’s high-grade story, with Behring Bore returning 4 metres at 6.98 g/t gold and Coodardy mineralisation now defined across about 500 metres of strike. A larger 2,500-metre RC program will test whether the zones continue at depth and along strike.

The FDA has agreed that EBR Systems’ WiSE cardiac pacing system does not require a field corrective action or recall following a February cybersecurity incident. The device maker says it has found no evidence of any impact on the safety or performance of fielded systems, while remediation work continues.

Jameson Resources has opened the retail leg of a A$5 million accelerated entitlement offer, giving eligible shareholders the chance to buy new shares at a 22.2% discount to the latest stated closing price. The company says institutional demand has already delivered about A$3.7 million, with a further A$1.59 million placement, but the retail component remains non-underwritten.

Peppermint Innovation has shifted from building its Philippines payments platform to commercialising it, but the FY26 report shows the business remains loss-making, balance-sheet constrained and dependent on future funding. The company reported A$217,720 in revenue, a A$2.40 million net loss and negative net assets of A$578,233.

Magnum Mining has confirmed broad shallow TREO enrichment across the 8.3 km² Feirinha target in Brazil, led by a 15-metre interval grading 2,190 ppm. The result is encouraging, but recoverability and mineral continuity remain untested as the company shifts to laboratory work.

Power Minerals has secured priority-project treatment from Minas Gerais for its Morro do Ferro rare earths project, directing future licensing through a specialised state pathway. The agreement improves institutional access but stops well short of environmental approval, project finance or a construction timetable.

Emyria has reported a sharp increase in FY26 revenue while expanding its psychedelic-assisted therapy network to five operational or announced clinics and 18 beds. Its first Sydney clinic is now fitted out and scheduled to begin treating patients in September, but utilisation and funding remain the next tests.

Income Asset Management Group has attributed a late director interest notice to an administrative oversight and miscommunication, after ASX questioned whether disclosure rules may have been breached. IAM says it has reiterated its director reporting process and will strengthen controls if required.

Great Northern Minerals (ASX: GNM) reported a $3.8 million loss for FY26 amid major US acquisitions, including the Iron Butte gold-silver project with a maiden resource of 480,000 oz gold and 11.5 million oz silver, and the Catalyst Ridge rare earths project. The company also completed a $2 million divestment of its remaining Golden Ant interest.